MetaADEDB 2.0 @ LMMD
rilmazafone
(KHINGHZNENOVFD-UHFFFAOYSA-N)
Structure
SMILES
NCC(=O)NCc1nc(nn1c1ccc(cc1C(=O)c1ccccc1Cl)Cl)C(=O)N(C)C.Cl
Molecular Formula:
C21H21Cl3N6O3
Molecular Weight:
511.789
Log P:
3.9750
Hydrogen Bond Acceptor:
9
Hydrogen Bond Donor:
3
TPSA:
123.21
CAS Number(s):
85815-37-8
Synonym(s)
1.
rilmazafone
2.
1-(2-(2-chlorobenzoyl)-4-chlorophenyl)-5-glycylaminomethyl-3-dimethylaminocarbonyl-1H-1,2,4-triazole hydrochloride
3.
450191-S
4.
S 450191
5.
S-450191
6.
rilmazafone hydrochloride
External Link(s)
MeSHC041075
PubChem Compound9958041
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Acute bronchitisOFFSIDES
2AdenocarcinomaOFFSIDES
3Alanine Aminotransferase IncreasedOFFSIDES
4Alcoholic IntoxicationOFFSIDES
5AlopeciaOFFSIDES
6Altered state of consciousnessOFFSIDES
7AnorexiaOFFSIDES
8Antibody test abnormalOFFSIDES
9ApathyOFFSIDES
10Aspiration PneumoniaOFFSIDES
11AuraOFFSIDES
12AutomatismOFFSIDES
13Blood GlucoseOFFSIDES
14Blood alkaline phosphatase increasedOFFSIDES
15Blood amylase increasedOFFSIDES
16Blood antidiuretic hormone increasedOFFSIDES
17Blood chloride decreasedOFFSIDES
18Blood creatine phosphokinase increasedOFFSIDES
19Blood creatinine increasedOFFSIDES
20Blood lactate dehydrogenase increasedOFFSIDES
21Blood osmolarity decreasedOFFSIDES
22Blood phosphorus decreasedOFFSIDES
23Blood potassium increasedOFFSIDES
24Blood sodiumOFFSIDES
25Blood thyroid stimulating hormone increasedOFFSIDES
26Blood triglycerides increasedOFFSIDES
27Blood urea increasedOFFSIDES
28BradycardiaOFFSIDES
29C-reactive proteinOFFSIDES
30Cancer PainOFFSIDES
31Carcinoembryonic antigen increasedOFFSIDES
32CataractOFFSIDES
33Cell marker increasedOFFSIDES
34Depressed Level of ConsciousnessOFFSIDES
35DiarrheaOFFSIDES
36Disease ProgressionOFFSIDES
37Disseminated Intravascular CoagulationOFFSIDES
38Dissociative Identity DisorderOFFSIDES
39Dry skinOFFSIDES
40Duodenal perforationOFFSIDES
41Duodenal ulcer perforationOFFSIDES
42DyscalculiaOFFSIDES
43DysphoniaOFFSIDES
44Dysthymic DisorderOFFSIDES
45Erosive gastritisOFFSIDES
46Erythema MultiformeOFFSIDES
47Eye painOFFSIDES
48Feeling of body temperature changeOFFSIDES
49Gastric ulcerOFFSIDES
50Glioblastoma MultiformeOFFSIDES
51Helicobacter pylori identification test positiveOFFSIDES
52HepatitisOFFSIDES
53High density lipoprotein increasedOFFSIDES
54HydronephrosisOFFSIDES
55Intestinal FistulaOFFSIDES
56Labile blood pressureOFFSIDES
57LacerationOFFSIDES
58Leukopenia neonatalOFFSIDES
59Limb injuryOFFSIDES
60LipaseOFFSIDES
61Lipodystrophy acquiredOFFSIDES
62Lymphocyte count decreasedOFFSIDES
63LymphomaOFFSIDES
64Malignant neoplasm progressionOFFSIDES
65Metastatic painOFFSIDES
66Middle insomniaOFFSIDES
67Muscle strainOFFSIDES
68Myoglobin blood increasedOFFSIDES
69NasopharyngitisOFFSIDES
70NeurilemmomaOFFSIDES
71Neuroleptic Malignant SyndromeOFFSIDES
72Neutrophil count decreasedOFFSIDES
73Optic NeuritisOFFSIDES
74Optic NeuropathyOFFSIDES
75OverdoseOFFSIDES
76PCO2 decreasedOFFSIDES
77PO2 decreasedOFFSIDES
78Pancreatic NeoplasmOFFSIDES
79PemphigusOFFSIDES
80PeriodontitisOFFSIDES
81PeritonitisOFFSIDES
82PleurisyOFFSIDES
83Pneumocystis jiroveci pneumoniaOFFSIDES
84PolymyositisOFFSIDES
85PolyuriaOFFSIDES
86Post procedural swellingOFFSIDES
87Respiratory FailureOFFSIDES
88RhabdomyolysisOFFSIDES
89SalpingitisOFFSIDES
90SchizophreniaOFFSIDES
91Self MutilationOFFSIDES
92SinusitisOFFSIDES
93Stevens-Johnson SyndromeOFFSIDES
94TetanyOFFSIDES
95Therapy regimen changedOFFSIDES
96TonsillitisOFFSIDES
97Urine osmolarity increasedOFFSIDES
98Ventricular FibrillationOFFSIDES
99Vocal Cord ParalysisOFFSIDES
100Wound ComplicationOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.